化学信息:
化学名 | (9S,10R,12R)-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG-3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID METHYL ESTER | |
简称 | K252a | |
别名 |
K 252; K 252a; K 252b; K 252c; K 252d; K-252; K-252a; K-252b; K-252c; K-252d; staurosporine aglycone; staurosporinone |
|
中文名 | 诺卡氏菌液 | |
化学式 | C27H21N3O5 | |
分子量 | 467.47 | |
CAS号 | 99533-80-9; 97161-97-2 | |
纯度 | ≥98% | |
溶剂/溶解度 |
Water <1mg/ml; DMSO 20mg/ml; Ethanol <1mg/ml |
|
溶液配制 | SC0362-10mM用DMSO配制。 |
生物信息:
产品描述 | Originally isolated from the soil fungi Nocardiopisis sp., K252a is a staurosporine analog that inhibits various protein kinases through competition with the ATP binding site. K252a is a reversible cell-permeable, potent inhibitor of phosphorylase kinase (IC50=1.7nM), protein kinase A (PKA) (IC50=140nM), and protein kinase C (PKC) (IC50=470nM). K252a is also known to inhibit protein kinase G and CaM kinase II. K252a inhibits nerve growth factor induced Trk activation (IC50=3nM), as well as downstream signaling. K252a is reported to induce apoptosis and cell cycle arrest through cdc25 and cdc2 inhibition. | ||||
信号通路 | PKC Signaling | ||||
靶点 | PKA | PKC | phosphorylase kinase | - | - |
IC50 | 140nM | 470nM | 1.7nM | - | - |
体外研究 | N/A | ||||
体内研究 | N/A | ||||
临床实验 | N/A | ||||
特征 | N/A |
相关实验数据(此数据来自于公开文献,碧云天并不保证其有效性):
酶活性检测实验 | |
方法 | N/A |
细胞实验 | |
细胞系 | N/A |
浓度 | N/A |
处理时间 | N/A |
方法 | N/A |
动物实验 | |
动物模型 | N/A |
配制 | N/A |
剂量 | N/A |
给药方式 | N/A |
产品编号 | 产品名称 | 包装 |
SC0362-10mM | K252a (PKC抑制剂) | 10mM×0.2ml |
— | 说明书 | 1份 |
保存条件:
-20℃保存,至少一年有效。